Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Axogen Appoints Michael Dale As CEO To Replace Karen Zaderej

PUBLIC · AXGNAug 09, 2024•almost 2 years ago

Position

President

Company

Axogen

Michael Dale

AlachuaBiotechnologyHealth CareMedical

Description

Axogen has appointed Michael Dale as its new CEO and director, effective Friday Aug. 9, replacing Karen Zaderej, who is leaving after 14 years as CEO. Michael Dale, a former Abbott executive, will bring over 30 years of leadership experience in medtech companies to drive commercial growth and profitability at Axogen.

Company Information

Company

Axogen

Location

Alachua, Florida, United States

About

Axogen is a medical technology company focused on the science, development, and commercialization of innovative solutions for peripheral nerve repair, with a mission to make nerve repair the expected standard of care. Through ongoing research, education, and close collaboration with surgeons and healthcare providers worldwide, Axogen advances clinical outcomes in nerve injury treatment. Its portfolio includes a comprehensive range of biologic and implantable solutions—such as Avance® Nerve Graft (acellular nerve allograft), Axoguard® Nerve Connector, Protector, Cap, and HA+ Nerve Protector™, as well as Avive+™ Soft Tissue Matrix—designed to support nerve regeneration and soft tissue healing across a wide variety of surgical applications.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Axogen's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months